2Dombrowski MP, Schatz M. ACOG Committee on Practice Bull etins-Obstetrics. ACOG practice bulletin: clinical management guidelines for number 90, February 2008 : asthma in pregnancy[J]. Ohstet Gynecol, 2008, 111 (2 Pt 1 ) : 457-464. 被引量：1
3Breton MC, Beauchesne MF, Lemiere C. Risk of perinatal mortality associated with inhaled corticosteroid use for the treatment of asthma during preguancy[J], ] Allergy Clin Immunol, 2010, 126(4): 772-777. 被引量：1
1Louik C, Schatz M, Hernemdez-Dlaz S, et al. Asthma in pregnancy and its pharmacologic treatment [ J ]. Ann Allergy Asthma Immunol, 2010,105(2) :110-7. 被引量：1
2National Ashma Education and Prevention Program Ashma and Preg- nancy Working Group expert panel report. Managing ashma during pregnancy: recommendations for pharmacologic treament 2004 up- date[J]. J Allergy Clin Immunol 2005 ,115( 1 ) :34. 被引量：1
3Dombrowski MP, Schatz M. Asthma in pregnancy[ J]. Clin Obstet Gyneco1,2010,53 (2) :301 - 10. 被引量：1
4Breton MC, Beanchesne MF, Lemire C, etal. Risk of perinatal mortality associated with inhaled corticosteroid use for the treatment of asthma during pregnancy [ J ]. Allergy Clin Immunol, 2010,126 (4) :772 -777. e2. 被引量：1
5Hodyl NA, et al. Fetal Glucocortieoid Regulated Pathways are not Affected by Inhaled Corticosteroid use for Asthma During Pregnancy [J]. Am J Respir Crit Care Med,2010,8. [ Epub ahead of print]. 被引量：1
6Mamazy JA, Schatz M. Treatment of ashma during pregnancy and perinatal outcomes [ J ]. Curr Opin Allergy Clin Immunol, 2005,5 C3) :229 -33. 被引量：1
